Related references
Note: Only part of the references are listed.Polyphosphate and RNA Differentially Modulate the Contact Pathway of Blood Clotting
Joshua M. Gajsiewicz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen
Ivan Ivanov et al.
THROMBOSIS AND HAEMOSTASIS (2017)
The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities
A. H. Schmaier
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation
Yasin Kokoye et al.
THROMBOSIS RESEARCH (2016)
Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant
Erin E. Soule et al.
NUCLEIC ACID THERAPEUTICS (2016)
Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody
Jon A. Kenniston et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk
Magnus Larsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Factor XI la inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit
Yiming Xu et al.
THROMBOSIS AND HAEMOSTASIS (2014)
A comparison of blood factor XII autoactivation in buffer, protein cocktail, serum, and plasma solutions
Avantika Golas et al.
BIOMATERIALS (2013)
Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer
R. S. Woodruff et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Plasma kallikrein: the bradykinin-producing enzyme
Jenny Bjorkqvist et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Hereditary angioedema: a bradykinin-mediated swelling disorder
Jenny Bjorkqvist et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Potent Anticoagulant Aptamer Directed against Factor IXa Blocks Macromolecular Substrate Interaction
Bruce Sullenger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity
K. M. Bompiani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Thrombotic Events Associated with C1 Esterase Inhibitor Products in Patients with Hereditary Angioedema: Investigation from the United States Food and Drug Administration Adverse Event Reporting System Database
Pranav K. Gandhi et al.
PHARMACOTHERAPY (2012)
Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: Murine Ortholog of the Fletcher Trait
J. Eileen Bird et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding
Alexey S. Revenko et al.
BLOOD (2011)
Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein
Jia Liu et al.
NATURE MEDICINE (2011)
The Plasma Contact System 2.0
Coen Maas et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2011)
An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase
Sai K. Buddai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system
Alvin H. Schmaier
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Crystal structure of an RNA aptamer bound to thrombin
Stephen B. Long et al.
RNA (2008)
Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation
E. Hooley et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Simultaneous generation of aptamers to multiple gamma-carboxyglutamic acid proteins from a focused aptamer library using DeSELEX and convergent selection
Juliana M. Layzer et al.
OLIGONUCLEOTIDES (2007)
Antidote-controlled platelet inhibition targeting von Willebrand factor with aptamers
S. Oney et al.
OLIGONUCLEOTIDES (2007)
The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema
Jerrold H. Levy et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Determinants of specificity in coagulation proteases
MJ Page et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Severe prekallikrein deficiency associated with homozygosity for an Arg94Stop nonsense mutation
DW Jones et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro
KA Tanaka et al.
THROMBOSIS RESEARCH (2004)
Antidote-mediated control of an anticoagulant aptamer in vivo
CP Rusconi et al.
NATURE BIOTECHNOLOGY (2004)
Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator
Z Shariat-Madar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Pathways for bradykinin formation and inflammatory disease
AP Kaplan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII
K Joseph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
